RxDoctor Payments Data

Lenore Blank, NP

Adult Health · West Orange, NJNPI 1831392562

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Impulse Dynamics (USA) Inc. accounts for 71.1% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2022 at $6,087 and has fallen 89.0% since, to $668 in 2025. Among adult health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,459in general payments, 2019–2025

Across 176 payments — averaging $53.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$7K
  • Novartis$492
  • Merck$250
  • Cvrx, Inc.$211
  • Pfizer$173
  • E.r. Squibb & Sons, L.L.C.$150
  • plus $1K from 30 others

What the payments were for

  • Consulting fees$1,00011%
  • Speaking & faculty fees$4,70050%
  • Travel & lodging$7798%
  • Food & beverage$2,96031%
  • Education$200%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,459 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$16,526
Medicare patients
46
Services billed
265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan80$72,388
EliquisApixaban42$50,073
JardianceEmpagliflozin30$21,561
Torsemide49$667
Metoprolol Succinate33$645
Atorvastatin Calcium55$608
Furosemide75$363
Amiodarone Hcl16$353
Carvedilol45$351
Spironolactone49$271
Ezetimibe12$259
Rosuvastatin Calcium14$195
ClopidogrelClopidogrel Bisulfate16$133
Potassium Chloride12$98
Pantoprazole Sodium11$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$492$72,38880 claims
PfizerEliquis$173$50,07342 claims
Boehringer IngelheimJardiance$65$21,56130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,135 adult health providers in New Jersey.

Other adult health in West Orange

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →